People taking popular GLP-1 medications such as Ozempic, Wegovy and Zepbound may face stigma from those closest to them, ...

McDonald's is testing protein-rich bowls and egg bites as it explores menu options to appeal to customers using GLP-1 drugs.

"Eighty-four percent of households with GLP-1 users visit McDonald's. This is an opportunity," McDonald's USA president Skye ...

Children taking GLP-1 medications (such as Victoza, Saxenda, Trulicity, and Ozempic) for weight loss, prediabetes, or type 2 ...

A brief report reviews emerging GLP-1 receptor co-agonists that also target GIPR, GCGR, and other receptors, examining their ...

New research suggest genetics may help explain why individual response to weight management and diabetes medications can vary ...

Researchers say little is known about the risks of GLP-1s for people who don't have an approved medical condition.

Dozens of lawsuits claim the drugs led to vision loss, though evidence is mixed.

The FDA took issue with the volume of GLP-1 drugs that Empower produces, suggesting in the warning letter that the changes do ...

A new study identified more than 1 million people taking weight-loss drugs without any apparent medical reason to do so.

Approximately one in eight U.S. adults is currently taking a GLP-1 drug. Usage is reshaping one of the country's biggest ...

Illinois Gov. JB Pritzker revealed to "CBS Mornings" that for the last two years he has been using a GLP-1 medication to lose weight.